287 related articles for article (PubMed ID: 19835834)
1. Comparison of bisulfite sequencing PCR with pyrosequencing for measuring differences in DNA methylation.
Reed K; Poulin ML; Yan L; Parissenti AM
Anal Biochem; 2010 Feb; 397(1):96-106. PubMed ID: 19835834
[TBL] [Abstract][Full Text] [Related]
2. Mapping the methylation pattern by bisulfite genomic sequencing of the E-cadherin promoter CpG island in nasopharyngeal carcinoma.
Kao RH; Huang LC; Hsu YH
Anticancer Res; 2002; 22(6C):4109-13. PubMed ID: 12553040
[TBL] [Abstract][Full Text] [Related]
3. Single-molecule polymerase chain reaction reduces bias: application to DNA methylation analysis by bisulfite sequencing.
Chhibber A; Schroeder BG
Anal Biochem; 2008 Jun; 377(1):46-54. PubMed ID: 18358818
[TBL] [Abstract][Full Text] [Related]
4. De novo quantitative bisulfite sequencing using the pyrosequencing technology.
Dupont JM; Tost J; Jammes H; Gut IG
Anal Biochem; 2004 Oct; 333(1):119-27. PubMed ID: 15351288
[TBL] [Abstract][Full Text] [Related]
5. Quantitative promoter hypermethylation analysis of cancer-related genes in salivary gland carcinomas: comparison with methylation-specific PCR technique and clinical significance.
Lee ES; Issa JP; Roberts DB; Williams MD; Weber RS; Kies MS; El-Naggar AK
Clin Cancer Res; 2008 May; 14(9):2664-72. PubMed ID: 18451230
[TBL] [Abstract][Full Text] [Related]
6. Methylation enrichment pyrosequencing: combining the specificity of MSP with validation by pyrosequencing.
Shaw RJ; Akufo-Tetteh EK; Risk JM; Field JK; Liloglou T
Nucleic Acids Res; 2006 Jun; 34(11):e78. PubMed ID: 16807314
[TBL] [Abstract][Full Text] [Related]
7. DNA methylation paradigm shift: 15-lipoxygenase-1 upregulation in prostatic intraepithelial neoplasia and prostate cancer by atypical promoter hypermethylation.
Kelavkar UP; Harya NS; Hutzley J; Bacich DJ; Monzon FA; Chandran U; Dhir R; O'Keefe DS
Prostaglandins Other Lipid Mediat; 2007 Jan; 82(1-4):185-97. PubMed ID: 17164146
[TBL] [Abstract][Full Text] [Related]
8. The temporal relationship between ABCB1 promoter hypomethylation, ABCB1 expression and acquisition of drug resistance.
Reed K; Hembruff SL; Sprowl JA; Parissenti AM
Pharmacogenomics J; 2010 Dec; 10(6):489-504. PubMed ID: 20125118
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic regulation of multidrug resistance 1 gene expression: profiling CpG methylation status using bisulphite sequencing.
Baker EK; El-Osta A
Methods Mol Biol; 2010; 596():183-98. PubMed ID: 19949925
[TBL] [Abstract][Full Text] [Related]
10. Allele-specific germ cell epimutation in the spacer promoter of the 45S ribosomal RNA gene after Cr(III) exposure.
Shiao YH; Crawford EB; Anderson LM; Patel P; Ko K
Toxicol Appl Pharmacol; 2005 Jun; 205(3):290-6. PubMed ID: 15922014
[TBL] [Abstract][Full Text] [Related]
11. Mapping of the methylation pattern of the MUC2 promoter in pancreatic cancer cell lines, using bisulfite genomic sequencing.
Hamada T; Goto M; Tsutsumida H; Nomoto M; Higashi M; Sugai T; Nakamura S; Yonezawa S
Cancer Lett; 2005 Sep; 227(2):175-84. PubMed ID: 16112420
[TBL] [Abstract][Full Text] [Related]
12. Loss of estrogen receptor-alpha expression is associated with hypermethylation near its ATG start codon in gastric cancer cell lines.
Woo IS; Park MJ; Choi SW; Kim SJ; Lee MA; Kang JH; Hong YS; Lee KS
Oncol Rep; 2004 Mar; 11(3):617-22. PubMed ID: 14767512
[TBL] [Abstract][Full Text] [Related]
13. Bisulfite-modified target DNA array for aberrant methylation analysis.
Zhou D; Qiao W; Yang L; Lu Z
Anal Biochem; 2006 Apr; 351(1):26-35. PubMed ID: 16516134
[TBL] [Abstract][Full Text] [Related]
14. Rapid analysis of CpG methylation patterns using RNase T1 cleavage and MALDI-TOF.
Schatz P; Dietrich D; Schuster M
Nucleic Acids Res; 2004 Dec; 32(21):e167. PubMed ID: 15576674
[TBL] [Abstract][Full Text] [Related]
15. Identification and quantification of differentially methylated loci by the pyrosequencing technology.
Dejeux E; El abdalaoui H; Gut IG; Tost J
Methods Mol Biol; 2009; 507():189-205. PubMed ID: 18987816
[TBL] [Abstract][Full Text] [Related]
16. Formamide as a denaturant for bisulfite conversion of genomic DNA: Bisulfite sequencing of the GSTPi and RARbeta2 genes of 43 formalin-fixed paraffin-embedded prostate cancer specimens.
Zon G; Barker MA; Kaur P; Groshen S; Jones LW; Imam SA; Boyd VL
Anal Biochem; 2009 Sep; 392(2):117-25. PubMed ID: 19505431
[TBL] [Abstract][Full Text] [Related]
17. 5' CpG island methylation analysis identifies the MAGE-A1 and MAGE-A3 genes as potential markers of HCC.
Qiu G; Fang J; He Y
Clin Biochem; 2006 Mar; 39(3):259-66. PubMed ID: 16516880
[TBL] [Abstract][Full Text] [Related]
18. DNA methylation analysis by bisulfite conversion, cloning, and sequencing of individual clones.
Zhang Y; Rohde C; Tierling S; Stamerjohanns H; Reinhardt R; Walter J; Jeltsch A
Methods Mol Biol; 2009; 507():177-87. PubMed ID: 18987815
[TBL] [Abstract][Full Text] [Related]
19. A reassessment of semiquantitative analytical procedures for DNA methylation: comparison of bisulfite- and HpaII polymerase-chain-reaction-based methods.
Fuso A; Scarpa S; Grandoni F; Strom R; Lucarelli M
Anal Biochem; 2006 Mar; 350(1):24-31. PubMed ID: 16445884
[TBL] [Abstract][Full Text] [Related]
20. Promoter hypermethylation-mediated inactivation of LRRC4 in gliomas.
Zhang Z; Li D; Wu M; Xiang B; Wang L; Zhou M; Chen P; Li X; Shen S; Li G
BMC Mol Biol; 2008 Nov; 9():99. PubMed ID: 18976507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]